Myocardial biomarkers in coronary microvascular dysfunction: Response to ranolazine

Myocardial biomarkers in coronary microvascular dysfunction: Response to ranolazine

Introduction: Patients with coronary microvascular dysfunction (CMD) are at increased risk of developing heart failure with preserved ejection fraction (HFpEF). We hypothesized that higher myocardial biomarkers (ultra-high sensitivity cardiac troponin I [u-hs-TnI]) and ventricular dysfunction (N-ter...

Full description

Saved in:

Bibliographic Details
Main Authors:	Katherine E. Hampilos, Anum Asif, Puja K. Mehta, Daniel S. Berman, Galen Cook-Wiens, Michael D. Nelson, Carl J. Pepine, C. Noel Bairey Merz, Janet Wei
Format:	Article
Language:	English
Published:	Elsevier 2025-04-01
Series:	American Heart Journal Plus
Subjects:	Coronary microvascular dysfunction Ischemia and no obstructive coronary artery disease Ranolazine Myocardial perfusion reserve index N-terminal pro-BNP Ultra-high sensitivity cardiac troponin I
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666602225000163
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cardio-protective role of ranolazine during percutaneous coronary intervention in chronic coronary syndrome patients
by: Ahmed G.Bakry, et al.
Published: (2025-05-01)

RANOLAZINE IN ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

Effects of ranolazine on angiogenesis and oxidant-antioxidant balance: an in vivo experimental model study
by: Fethullah Kayan, et al.
Published: (2025-07-01)

Fluoroscopic methods of assessment of coronary microvascular dysfunction – a review of literature
by: R. Grigorov, et al.
Published: (2025-05-01)

Neuroprotective effect of ranolazine in mice's model of Alzheimer's disease
by: Mariam H. Sadiq, et al.
Published: (2024-06-01)

Ranolazine as a therapeutic agent for diabetic cardiomyopathy: reducing endoplasmic reticulum stress and inflammation in type 2 diabetic rat model
by: Matin Mohyadini, et al.
Published: (2025-05-01)

Intracoronary acetylcholine for vasospasm provocation in women with ischemia and no obstructive coronary artery disease
by: Benita Tjoe, et al.
Published: (2025-05-01)

Sex differences and determinants of coronary microvascular function in asymptomatic adults with type 2 diabetes
by: Jian L. Yeo, et al.
Published: (2025-01-01)

Interplay between subclinical calcified atherosclerosis and coronary microvascular dysfunction in patients with normal perfusion imaging
by: Krishna K. Patel, et al.
Published: (2025-09-01)

Prognostic impact of coronary microvascular dysfunction in patients with myocardial infarction evaluated by new angiography-derived index of microvascular resistance
by: Benoit Caullery, et al.
Published: (2025-02-01)

CLINICAL CASE OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH MICROVASCULAR ANGINA
by: Yu. I. Minyuk, et al.
Published: (2020-03-01)

Neuroprotective role of ranolazine in Parkinson disease: Drosophila melanogaster model
by: Parvesh, et al.
Published: (2025-01-01)

Coronary Microvascular Dysfunction: Epidemiology, Clinical Presentation, Diagnosis and Treatment
by: E. L. Trisvetova
Published: (2023-05-01)

Association between peripheral and coronary microvascular function and the impact of myocardial bridging
by: Takumi Toya, et al.
Published: (2025-04-01)

The Role of Circulating Biomarkers in Patients with Coronary Microvascular Disease
by: Rossella Quarta, et al.
Published: (2025-01-01)

Reduced retinal microvascular density in women with coronary microvascular dysfunction: A pilot study
by: Sakshi Shiromani, et al.
Published: (2025-03-01)

Coronary microvascular dysfunction: a review of its association with extracardiac organ pathologies
by: Yuting Duan, et al.
Published: (2025-08-01)

Effect of long-term nicorandil therapy on myocardial perfusion parameters according to triphosadenine stress-volume computed tomography in a patient with non-obstructive coronary artery disease: a care report
by: O. F. Egorkina, et al.
Published: (2023-10-01)

Comparison of left ventricular myocardial perfusion parameters according to adenosine triphosphate stress computed tomography myocardial perfusion with clinical parameters of patients with nonobstructive coronary artery disease
by: O. F. Egorkina, et al.
Published: (2024-12-01)

Epicardial Fat Tissue: A Potential Marker for Coronary Microvascular Dysfunction
by: Waiel Abusnina, et al.
Published: (2025-02-01)

Prevalencia de angina microvascular en pacientes del Centro de Investigaciones Médico Quirúrgicas
by: Lázaro Isralys Aldama Pérez, et al.

Association between the Tpeak‐Tend interval on admission and coronary microvascular dysfunction in Takotsubo syndrome
by: Kyohei Onishi, et al.
Published: (2025-06-01)

Invasive minimal Microvascular Resistance Is a New Index to Assess Microcirculatory Function Independent of Obstructive Coronary Artery Disease
by: Guus A. de Waard, et al.
Published: (2016-12-01)

Coronary microvascular dysfunction in post-PCI target vessels: a systematic review and meta-analysis of prevalence and associated outcomes
by: Yunze Li, et al.
Published: (2025-08-01)

Elevation of Cardiac Biomarkers in COVID-19 As a Major Determinant for Mortality: A Systematic Review
by: Tracy Anabella Hermansyah, et al.
Published: (2022-01-01)

Prognostic impact of type 2 diabetes mellitus and coronary microvascular dysfunction in patients undergoing rotational atherectomy during PCI
by: Lijun Feng, et al.
Published: (2025-07-01)

Prognostic Value of the Triglyceride-Glucose Index Combined with Non-HDL-C/HDL-C Ratio for Predicting Coronary Microvascular Dysfunction in ACS Patients Post-PCI
by: Hang S, et al.
Published: (2025-03-01)

Coronary artery volume to left ventricular myocardial mass ratio in detecting primary microvascular angina: a retrospective observational study in Chinese population
by: Linlin Sun, et al.
Published: (2025-07-01)

Prognostic impact of coronary microvascular dysfunction assessed by AMR in acute coronary syndrome patients with chronic kidney disease
by: Ziyu Guo, et al.
Published: (2025-01-01)

Angiographic Microvascular Resistance Is an Independent Predictor of Adverse Clinical Outcomes After Transcatheter Aortic Valve Replacement
by: Wence Shi, et al.
Published: (2025-03-01)

Coronary Microvascular Disease Early After Myocardial Infarction: Diagnostic Approach and Prognostic Value—A Narrative Review
by: Stefanos Sokratous, et al.
Published: (2025-05-01)

Should We Revisit the Clinical Value of Fractional Flow Reserve in the Era of Coronary Microvascular Dysfunction?
by: Georgiana Pintea Bentea, et al.
Published: (2025-04-01)

Metabolic and Proteomic Profiling of Coronary Microvascular Dysfunction: Insights from Rat Models
by: Yan Lu, et al.
Published: (2024-10-01)

Analytical Performance of the New Sysmex High-Sensitivity Troponin T Assay
by: Chin Shern Lau, et al.
Published: (2025-07-01)

Relationship Between Noninvasive Doppler-Derived Coronary Flow Reserve Measured by Transthoracic Echocardiography and Angiography Thermodilution-Measured Coronary Flow Reserve and the Index of Microcirculatory Resistance in Patients with Non-Obstructive Coronary Arteries
by: Milenko Čanković, et al.
Published: (2025-02-01)

Cardiac biomarkers for screening and prognostication of cardiac dysfunction in critically ill patients
by: Oscar Cavefors, et al.
Published: (2024-12-01)

Adverse cardiovascular events in patients with coronary microvascular dysfunction: results of a 12-month follow-up with a control group
by: K. V. Kopyeva, et al.
Published: (2023-04-01)

Dynamics of LV myocardial perfusion according to volumetric CT of the heart with a pharmacological test with ATP in comparison with clinical manifestations of stable coronary heart disease, risk factors and the nature of drug therapy in patients with non-obstructive coronary heart disease
by: O. F. Egorkina, et al.
Published: (2025-06-01)

Prognostic Value of Cardiac Troponin T and Sex in Patients Undergoing Elective Percutaneous Coronary Intervention
by: Yukinori Harada, et al.
Published: (2016-12-01)

Significance of inflammation markers in patients with coronary microvascular dysfunction and non-obstructive coronary artery disease
by: K. V. Kop’eva, et al.
Published: (2023-07-01)